Shanghai Haixin Group Co Ltd
900917
Company Profile
Business description
Shanghai Haixin Group Co Ltd is a China-based company engaged in the pharmaceuticals business. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. Further, it is also involved in financial investment, industrial plant rental management, and textile products business. Geographically, the activities are carried out through China.
Contact
688 Changxing Road
Dongjing Songjiang
Shanghai201619
CHNT: +86 2157698100
Sector
Industrials
Stock type
Sensitive
Industry
Conglomerates
Fiscal Year End
31 December 2026
Employees
715
Stocks News & Analysis
stocks
AI lands a blow on some Aussie stocks – yet stands to benefit others
AI is reshaping ASX tech moats - but some are more insulated than others.
stocks
This might be the best core stock bargain in the US market today
Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.
stocks
Data center demand drives strong earnings outlook for SGM
Sims guides huge earnings upgrade as data center metals demand spikes.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,552.60 | 77.00 | 0.91% |
| CAC 40 | 7,548.73 | 116.89 | -1.52% |
| DAX 40 | 21,951.14 | 429.05 | -1.92% |
| Dow JONES (US) | 45,577.47 | 443.96 | -0.96% |
| FTSE 100 | 9,767.87 | 150.46 | -1.52% |
| HKSE | 24,382.47 | 894.85 | -3.54% |
| NASDAQ | 21,647.61 | 443.08 | -2.01% |
| Nikkei 225 | 51,515.49 | 3,723.91 | -6.74% |
| NZX 50 Index | 12,899.72 | 90.27 | -0.69% |
| S&P 500 | 6,506.48 | 100.01 | -1.51% |
| S&P/ASX 200 | 8,365.90 | 82.40 | 0.99% |
| SSE Composite Index | 3,813.28 | 143.77 | -3.63% |